Phase I Study of Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic Irinotecan for Unresectable Hepatic Metastases From Colorectal Cancer
- 15 May 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (10) , 2687-2695
- https://doi.org/10.1200/jco.2001.19.10.2687
Abstract
PURPOSE: To determine the maximum-tolerated dose (MTD) and dose-limiting toxicities of concurrent systemic irinotecan and hepatic arterial infusion (HAI) of floxuridine (FUDR) and dexamethasone in ...Keywords
This publication has 24 references indexed in Scilit:
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Liver resection for colorectal metastases.Journal of Clinical Oncology, 1997
- Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.Journal of Clinical Oncology, 1994
- A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasoneversus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancerCancer, 1992
- A 5-Year Study of Cryosurgery in the Treatment of Liver TumorsArchives of Surgery, 1991
- Spinal Anesthesia Using Subcutaneously Implanted Pumps for Intrathecal Drug InfusionAnesthesia & Analgesia, 1991
- Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinomaCancer, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945